Quick Answer
Solventum Corp reported R&D Expense of $739.00 million for fiscal year 2025.
Solventum Corp R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $739.00M | -4.6% |
| 2024 | $775.00M | +2.2% |
| 2023 | $758.00M | -1.2% |
| 2022 | $767.00M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $183.00M | -3.2% | -3.2% |
| June 30, 2025 | $189.00M | -1.6% | -2.1% |
| March 31, 2025 | $193.00M | -1.0% | +2.1% |
| September 30, 2024 | $189.00M | +5.0% | -1.6% |
| June 30, 2024 | $192.00M | -0.5% | -1.5% |
| March 31, 2024 | $195.00M | +0.0% | +8.3% |
| September 30, 2023 | $180.00M | — | -6.7% |
| June 30, 2023 | $193.00M | — | -1.0% |
- Solventum Corp showed a decrease of -4.6% in R&D Expense compared to the prior fiscal year.
- Over the 2022–2025 period, Solventum Corp’s r&d expense has declined by 3.7% (from $767.00 million to $739.00 million).
- The most recent figure is from Solventum Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: